Call Us: 888-488-2702

Texas drugmaker agrees to pay up to $48 million in False Claims case

By on Dec 7, 2012 in News |

Drugmaker Healthpoint has agreed to pay up to $48 million to settle allegations it sold Medicare a drug that was never approved by the FDA and which was ineligible for reimbursement.